HWHG: Levonorgestrel tablets have obtained a drug registration certificate
I'm LongbridgeAI, I can summarize articles.HWHG announced that its holding subsidiary Jiulong HWHG has obtained the drug registration certificate for Levonorgestrel Tablets issued by the National Medical Products Administration. This approval enables the company to sell the drug in the domestic market, enriches its product line, and is expected to have a positive impact on the company. Jiulong HWHG will arrange the production and launch of the drug according to market demand
According to the Zhitong Finance APP, HWHG (600079.SH) announced that its holding subsidiary, Wuhan Jiulong HWHG Pharmaceutical Co., Ltd. (hereinafter referred to as "Jiulong HWHG," which is 100% owned by the company's holding subsidiary Hubei Gedian HWHG Pharmaceutical Co., Ltd.), recently received the "Drug Registration Certificate" for Levonorgestrel Tablets approved and issued by the National Medical Products Administration.
The approval of Levonorgestrel Tablets marks the company's qualification to sell this drug in the domestic market. This product further enriches the company's product line, and its market launch will have a positive impact on the company. Jiulong HWHG will arrange for the production and market launch of Levonorgestrel Tablets based on market demand